Complicated urinary tract infection (UTI) is associated with a condition [eg structural or functional abnormalities of the genitourinary tract (GUT)] or the presence of an underlying disease that interferes with host defense mechanisms, which increases the risks of acquiring infection, failing therapy or having recurrent infections. The successful treatment of a complicated UTI considers effective antimicrobial therapy, optimal management of the underlying abnormalities or other diseases and adequate life-supporting measures.

Urinary Tract Infection in Women - Complicated References

  1. Drekonja DM, Johnson JR. Urinary tract infections. Prim Care. 2008 Jun;35(2):345-367. http://www.ncbi.nlm.nih.gov/pubmed/?term=18486719. PMID: 18486719
  2. Institute for Clinical Systems Improvement. ICSI healthcare guideline: uncomplicated urinary tract infections in women, 10th ed. 2006 Jul:1-21. http://www.icsi.org. Accessed 10 Sep 2012
  3. Infectious Diseases Society of the Republic of China, Medical Foundation in Memory of Dr. Deh Lin-Cheng, Foundation of Professor Wei-Chuan Hsien for Infectious Diseases Research and Education, Lee CY's Research Foundation for Pediatric Infectious Diseases and Vaccine. Guidelines for antimicrobial therapy of urinary tract infections in Taiwan. J Microbiol Immunol Infect. 2000 Dec;33(4):271-272. http://www.ncbi.nlm.nih.gov/pubmed/?term=11269375. PMID: 11269375
  4. Neal DE Jr. Complicated urinary tract infections. Urol Clin North Am. 2008 Feb;35(1):13-22. http://www.ncbi.nlm.nih.gov/pubmed/18061020. PMID: 18061020
  5. Orenstein R, Wong ES. Urinary tract infections in adults. Am Fam Physician. 1999 Mar;59(5):1225-1234, 1237. http://www.ncbi.nlm.nih.gov/pubmed/?term=10088877. PMID: 10088877
  6. Naber KG, Bergman B, Bishop MC, et al for Urinary Tract Infection (UTI) Working Group of the Health Care Office (HCO) of the European Association of Urology (EAU). EAU guidelines for the management of urinary and male genital tract infections. Eur Urol. 2001 Nov;40(5):576-588. http://www.ncbi.nlm.nih.gov/pubmed/?term=11752870. PMID: 11752870
  7. Rubenstein JN, Schaeffer AJ. Managing complicated urinary tract infections: the urologic view. Infect Dis Clin North Am. 2003 Jun;17(2):333-351. http://www.ncbi.nlm.nih.gov/pubmed/?term=12848473. PMID: 12848473
  8. Task Force on UTI 2003-04, Philippine Practice Guidelines Group in Infectious Diseases. Urinary tract infections in adults: clinical practice guidelines update 2004. PPGG-ID Philippine Society for Microbiology and Infectious Diseases. 2004;1(1). http://citeseerx.ist.psu.edu.
  9. Nicolle LE. Complicated urinary infection, including postsurgical and catheter-related infections. In: Cohen J, Powderly WG, Berkley SF, et al. Cohen and Powderly: Infectious diseases. 2nd. Edinburgh: Mosby; 2004.
  10. Sobel JD, Kaye D. Urinary tract infections. In: Mandell GL, Bennett JE, Dolin R, eds. Mandell, Douglas and Bennett’s Principles and Practice of Infectious Diseases. 6th. Philadelphia: Elsevier Churchill Livingstone, Inc; 2005.
  11. Ministry of Health Singapore. Clinical practice guidelines: use of antibiotics in urinary tract infections. MOH (Singapore). http://www.moh.gov.sg. Jan 2002.
  12. Scottish Intercollegiate Guidelines Network. Management of suspected bacterial urinary tract infection in adults. SIGN. www.sign.ac.uk. Jul 2006.
  13. Hooton TM. Acute complicated cystitis and pyelonephritis. UpToDate. http://www.uptodate.com. 30 May 2014.
  14. Grabe M, Bartoletti R, Bjerklund Johansen TE, et al. Guidelines on urological infections. European Association of Urology. http://uroweb.org. Mar 2015. Accessed 28 Oct 2015.
  15. Bonkat G, Bartoletti RR, Bruyère F, et al. Urological infections. European Association of Urology (EAU). https://uroweb.org. 2020. Accessed 07 Apr 2020.
  16. Hooton TM, Gupta K. Acute complicated urinary tract infection (including pyelonephritis) in adults. UpToDate. https://www.uptodate.com. 21 Aug 2019. Accessed 23 Apr 2020.
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS JPOG - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Pearl Toh, 12 Jan 2021
Adding the CDK4/6 inhibitor abemaciclib to an endocrine therapy of fulvestrant extends overall survival (OS) compared with fulvestrant alone in East Asian patients with hormone receptor-positive (HR+), HER2-negative advanced breast cancer (ABC) who have progressed on prior endocrine therapy, consistent with results from the overall population, updated analysis of the global, phase III MONARCH 2 study has shown.